Clinical trials are the pivotal stage in development of life-improving drugs before they go on the market.

But they have grown too costly and lengthy, and are freighted with inefficiencies. 

Today, clinical trials are plagued by a lack of communication, mutual trust and transparency among the various stakeholders. Investigators, service providers and sponsors pursue interests that can be at odds.

Drug makers who scrutinize their service providers better and take more ownership of the process stand a better chance of getting reliable answers more quickly to a prospective drug's viability. 

Meet the Expert

Sergei Varshavsky PhD

Consultant Sergei Varshavsky PhD

About Sergei

  • Launched his first international clinical trial in a cardiology clinic basement in 1989.
  • Founded Evidence Clinical & Pharmaceutical Research; built it into a leading contract research organization in Eastern Europe before it was acquired by Worldwide Clinical Trials.
  • Clients have included Pfizer, GlaxoSmithKline (GSK), Bristol-Myers Squibb, Boehringer Ingelheim.
  • Has conducted hundreds of major clinical trials and authored more than 40 published scientific papers.

Experience

Chairman & CEO • Confidence Pharmaceutical Research
Jan, 2014 — Present
  • Confidence Pharmaceutical Research is a contract research organization (CRO) founded earlier this year, reuniting Dr. Sergei Varshavsky with Dr. Efim Kelman, the original partners in Evidence Clinical & Pharmaceutical Research.
President • Preference PEO
May, 1991 — Present
  • Preference PRO conducts cultural adaptions of quality of life questionnaires, serving the global pharmaceutical industry and scientific community.
VP, Scientific Affairs • Worldwide Clinical Trials
2008 — 2011
  • WCT is a global contract research organization with medical and scientific personnel in more than 60 countries.
Chairman & CEO • Evidence Clinical & Pharmaceutical Research
Dec, 1989 — Mar, 2008
  • Launched his first international clinical trial in a St. Petersburg cardiology clinic basement.
  • Built Evidence into a leading contract research organization Eastern Europe, with 350 employees, and operating seven offices in five countries.
  • Clients included Pfizer, GlaxoSmithKline (GSK), Bristol-Myers Squibb, Boehringer Ingelheim.
  • Acquired in 2008 by Worldwide Clinical Trials.
Researcher • Research Institute of Cardiology
1988 — 1993

Education

St. Petersburg (Russia) Medical Academy of Postgraduate Studies
PhD, Cardiology, 1993
St. Petersburg Medical University
MD, Medicine, 1983

Security Clearances

Has held security clearances with the National Institutes of Health.

Committees

  • Has served on the steering committees of multinational clinical trials.

Publications

  • Has published 49 scientific papers.
Packages with Sergei starting from $450

Your Expert Package Includes:

Best Practices

Access to ALL Best Practices authored by TrustedPeer Expert Sergei Varshavsky PhD on this topic.

Pre-Meeting Discovery Process

Review and analysis of your issue with pre-meeting discovery questions by Sergei, followed by a 30- or 60-minute one-on-one call. Sample

One+-on-One Call

Your (+colleagues) meeting is directed and focused from the first minute.

Meeting Summary Report

After your call, Sergei completes a Meeting Summary Report to provide you with the session’s discussion topics, analysis, assessment and recommendations for next steps. Sample

Post-Meeting Engagement

After your meeting, continue your relationship with Sergei on your own, or with TrustedPeer’s support.
Loading...